Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis.

Arthritis research & therapy

Volumn 7, Issue 1, 2005, Pages

  Allanore, Yannick ^a   Borderie, Didier ^a   Périanin, Axel ^a   Lemaréchal, Hervé ^a   Ekindjian, Ohvanesse Garabed ^a   Kahan, André ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; HYBRID PROTEIN; NIFEDIPINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; SUPEROXIDE;

AGED; ARTICLE; CELL CULTURE; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; MONOCYTE; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN PROCESSING; SYSTEMIC SCLEROSIS;

AGED; ANTIOXIDANTS; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; DRUG EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; NIFEDIPINE; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT FUSION PROTEINS; SCLERODERMA, SYSTEMIC; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE;

EID: 33645017377     PISSN: None     EISSN: 14786362     Source Type: Journal    
DOI: None     Document Type: Article

References (0)